rifapentine and isoniazid combination therapy for the treatment of latenttuberculosis infection in Ontario (PDF). [1 December 2022]. (原始内容存档 (PDF)于2 December
Xu K, Li Y, Zhang Y, Wu W. Progress on diagnosis and treatment of latenttuberculosis infection. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):691-696
studies. It should not be used in people who have active infections or latenttuberculosis, who have low 白血球 counts, or who are taking TNF inhibitor(英语:TNF
FDA因為該藥物引起一些嚴重的感染,而曾在2008年5月2日對依那西普發出黑框警告。根據報導,使用依那西普會導致嚴重感染和敗血症(包括潛伏性結核(英语:latenttuberculosis)和B型肝炎感染復發),甚至是死亡。 發生注射部位反應(英语:Injection site reaction)(例如發紅和疼痛)的案例很常見,比率約為11